Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

BioMarin Pharmaceutical Company Profile (NASDAQ:BMRN)

Consensus Ratings for BioMarin Pharmaceutical (NASDAQ:BMRN) (?)
Ratings Breakdown: 7 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.46)
Consensus Price Target: $85.00 (13.32% upside)

Current Analysts' Coverage Summary for BioMarin Pharmaceutical (NASDAQ:BMRN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/16/2014SunTrustInitiated CoverageBuy$100.00ViewTweet This Rating  Share This Rating on StockTwits
9/15/2014ZacksReiterated RatingNeutral -> Neutral$71.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014Credit SuisseInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
7/31/2014NomuraBoost Price TargetNeutral$77.00 -> $82.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
3/24/2014Goldman SachsDowngradeBuy -> Neutral$84.00ViewTweet This Rating  Share This Rating on StockTwits
2/19/2014BarclaysBoost Price TargetEqual Weight$73.00 -> $76.00ViewTweet This Rating  Share This Rating on StockTwits
2/19/2014Jefferies GroupReiterated RatingBuy$87.00ViewTweet This Rating  Share This Rating on StockTwits
2/19/2014Citigroup Inc.Boost Price Target$79.00 -> $90.00ViewTweet This Rating  Share This Rating on StockTwits
1/14/2014Deutsche BankBoost Price TargetBuy$75.00 -> $85.00ViewTweet This Rating  Share This Rating on StockTwits
11/29/2013TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
11/26/2013Piper JaffrayInitiated CoverageOverweight$87.00ViewTweet This Rating  Share This Rating on StockTwits
11/19/2013Wells Fargo & Co.Reiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
10/25/2013WedbushReiterated RatingHold$88.00ViewTweet This Rating  Share This Rating on StockTwits
9/18/2013William BlairReiterated RatingHold$88.00ViewTweet This Rating  Share This Rating on StockTwits
9/18/2013RBC CapitalReiterated RatingBuy$77.00ViewTweet This Rating  Share This Rating on StockTwits
9/18/2013Stifel NicolausDowngradeBuy -> Hold$70.00ViewTweet This Rating  Share This Rating on StockTwits
9/16/2013Bank of AmericaReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
9/5/2013Canaccord GenuitySet Price TargetBuy$71.00 -> $85.00ViewTweet This Rating  Share This Rating on StockTwits
6/3/2013Leerink SwannReiterated RatingOutperform -> PositiveViewTweet This Rating  Share This Rating on StockTwits
4/18/2013Lazard LtdBoost Price TargetBuy$71.00 -> $77.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2013S&P Equity ResearchDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Janney Montgomery ScottInitiated CoverageBuy$60.00ViewTweet This Rating  Share This Rating on StockTwits
1/2/2013JPMorgan Chase & Co.Reiterated RatingOverweight$60.00ViewTweet This Rating  Share This Rating on StockTwits
12/4/2012Robert W. BairdReiterated RatingOutperform$54.00ViewTweet This Rating  Share This Rating on StockTwits
11/6/2012Summer StreetBoost Price TargetBuy$52.00 -> $69.00ViewTweet This Rating  Share This Rating on StockTwits
11/6/2012Brean CapitalDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/24/2012 forward)
Discuss BioMarin Pharmaceutical